* 2-Amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone hydrochloride (bk-2C-B) has recently emerged as a new psychoactive substance (NPS). It is most commonly consumed orally, although there are indications that it might also be ingested by inhalation or 'smoking'. Information about the stability of bk-2C-B when exposed to heat is unavailable and the potential for pyrolytic degradation and formation of unknown substances available for inhalation prompted an investigation using a simulated 'meth pipe' scenario. Twelve products following pyrolysis of bk-2C-B were detected and verified by organic synthesis of the corresponding standards. In addition, 2-amino-1-(4-iodo-2,5-dimethoxyphenyl)ethanone hydrochloride (bk-2C-I) was characterized for the first time and subjected to pyrolysis as well. Similar products were formed, which indicated that the replacement of the bromo with the iodo substituent did not affect the pyrolysis pattern under the conditions used. Two additional products were detected in the bk-2C-I pyrolates, namely 1-(2,5-dimethoxyphenyl)-ethanone and 1-iodo-4-ethenyl-5-methoxyphenol. The potential ingestion of pyrolysis products with unknown toxicity adds an element of concern.
Introduction
Many ring-substituted phenethylamines show psychoactive and psychedelic effects in humans [1] and these are based on the now considered prototypical set of substances published in PIHKAL. [2] The extent of their control varies across the globe and depends on the nature of legislative control mechanisms that are in place. A number of phenethylamines not specifically controlled internationally or those exemplifying a development beyond the traditional PIHKAL compounds [3] are sometimes captured under the term new psychoactive substances (NPS). [4] In the last decade, the number of unregulated psychoactive substances available for purchase via the Internet and high street shops has grown significantly, which has created challenges for policymakers, healthcare professionals, law enforcement, and researchers across disciplines. [5] [6] [7] One of the phenethylamine analogues emerging on the NPS market in more recent years was 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone hydrochloride (bk-2C-B) (Figure 1 ), the beta-keto analogue of the popular psychedelic 2-(4-bromo-2,5-dimethoxyphenyl)ethan-1-amine (2C-B). The detection of bk-2C-B on the European market was first reported to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in December 2013 [8] and it has since been detected in other European countries including, for example Italy. [9] The synthesis of bk-2C-B was first published in 2004 where it served as an intermediate for the preparation of 2-(4-bromo-2,5-dimethoxyphenyl)morpholine. [10] The synthesis and extensive analytical characterization of bk-2C-B, verifying the identification of this substance obtained from a test purchase from an Internet vendor, was reported more recently. Furthermore, it was reported that bk-2C-B was prone degradation when analyzed by GC-MS without derivatization. [11] Another report complementing the analytical data related to bk-2C-B is also available. [12] Recreational use of bk-2C-X has been reported to be closer to MDMA than those of the analogous 2C-X. Users report that the effects begin within 15-20 min and increase over 60-90 min. The general consensus is that bk-2C-B lasts about 10 h, noticeably longer than 2C-B. Negative effects of snorting include severe burning and purple mucus. Gastrointestinal effects including severe diarrhoea are also common. [13] The few user reports on the forums indicate that bk-2C-I also lasts longer, but does not produce as intense a high as bk-2C-I. Concerns were expressed about the toxicity of iodine.
Drugs may be ingested by various routes of administration including 'smoking'. The most common route of administration associated with ring-substituted phenethylamines is the oral route and this appears to apply to bk-2C-B as well, although there is some indication that this substance may also be smoked. Mixing bk-2C-B with marijuana, either as a solid dose or smoked, has been reported by some users to intensify the effects of both drugs. [14] A key concern associated with the conditions encountered during pyrolysis is the formation of degradation products that may be formed during smoking and knowledge about the behaviour of drugs under these harsh conditions provide important information on potential biomarkers and toxicity. [15] In the present study, bk-2C-B was subjected to pyrolysis conditions for analysis of condensed residues formed after vaporization. Furthermore, the analytical characterization and pyrolysis of 2-amino-1-(4-iodo-2,5-dimethoxyphenyl)ethanone hydrochloride(bk-2C-I) (Figure 1 ), a substance that has not yet been described in the literature, has also been included in this investigation.
Experimental Materials
A sample of bk-2C-B as the hydrogen chloride salt was obtained as a test purchase from an Internet vendor and 1-(4-Bromo-2,5-dimethoxyphenyl)-2-bromoethanone (11) and 1-(4-bromo-2,5-dimethoxyphenyl)ethanone (6) were prepared as reported previously.
[11] 1-Bromo-2,5-dimethoxy-4-methylbenzene (1a), 1,4-dibromo-2,5-dimethoxybenzene (5), and all reagents were obtained from Sigma-Aldrich (Arklow, Co. Wicklow, Ireland). A sample of bk-2C-I was donated by an Internet retailer in 2015. (9) This was prepared via the sulfuryl chloride method previously reported for 2-chloro-1-(4-methylphenyl)propanone [16] 5-(4-Bromo-2,5-dimethoxyphenyl)oxazole (10) A mixture of 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone hydrobromide (177 mg, 0.5 mmol), p-toluenesulfonic acid (5 mg) and triethyl orthoformate (2 mL) was heated at 140°C for 3 h. The volatiles were removed under vacuum and the residue was purified by preparative TLC (silica gel; cyclohexane/EtOAc, 1/1) to afford a light-brown solid ( A mixture of 2-(4-bromo-2,5-dimethoxyphenyl)ethanol (130 mg, 0.5 mmol, prepared by the reduction of 2-(4-bromo-2,5-dimethoxyphenyl)acetic acid with borane-THF) and thionyl chloride (2 mL) was refluxed for 2 h. (Ar-CH), 110.26 (Ar-C), 57.01 (OMe), 56.04 (OMe), 43.46 (CH 2 ), 30.33 (CH 2 ). For this compound, sufficient ionization under the employed HR-ESI-MS conditions was not observed for high accuracy mass analysis.
1-Bromo-2,5-dimethoxy-4-vinylbenzene (3)
Sodium hydride (180 mg, 7.5 mmol) was added to methyltriphenylphosphonium bromide (1.34, 3.75 mmol) in diethyl ether (25 mL) at 0°C and the mixture was stirred for 1 h. 4-Bromo-2,5-dimethoxybenzaldehyde (612 mg, 2.5 mmol) in diethyl ether (10 mL) was then added and the mixture was stirred for 3 h at room temperature. Saturated aqueous sodium carbonate was then added, the organic layer collected, dried (anhydrous magnesium sulphate), evaporated to dryness and purified by preparative TLC (silica gel; cyclohexane/EtOAc, 7/3) to afford a colourless solid (178 Helium was used as the carrier gas (1.1 mL/min). The temperature program started at 100°C with a ramp rate of 15°C per min up to 300°C followed by a 34.7 min hold for a total run time of 48 min. The solvent delay was set for 4 min. Nuclear magnetic resonance (NMR) spectra 1 H (600 MHz) and 13 C (150 MHz) were recorded on a Bruker AV600 NMR spectrometer using a 5 mm TCI cryoprobe.
HR-ESI mass spectra were recorded by direct injection into an LTQ Orbitrap Discovery (Thermo Fisher, UK). Samples were dissolved in acetonitrile/water (1:1, containing 0.1% formic acid) and infused at a rate of 5 μL/min. Full accurate high-resolution (30 000) mass scans were performed in positive electrospray mode. Measured accurate masses were within ±5 ppm of the theoretical masses. The following conditions were used: drying gas (N 2 ) 10 L/min, capillary temperature 310°C, spray voltage 4 V, capillary voltage 22 V and tube lens 77 V.
Pyrolysis
A sample of the drug (5-9 mg) was loaded into an aluminium foil boat, placed in the bottom of a 20-mL crimp vial, and heated with a disposable lighter for approximately 30 s until yellow vapours formed in the vial and a brown tar formed in the boat. The foil cup was removed and the flask was rinsed with 1 mL of acetonitrile to dissolve the residues for gas chromatography-mass spectrometry (GC-MS) analysis. Acetylation was performed using 100 μL of acetic anhydride and heating at 70°C for 3 h. The vial was cooled to room temperature and the contents analyzed by GC-MS. For trimethylsilyl (TMS) derivatization, the residue was taken up in N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA)/ toluene (1/1) and analyzed by GC-MS. Ethylation was performed by dissolving the residue in acetone (200 μL). Iodoethane (50 μL) and anhydrous potassium carbonate (approx. 20 mg) were added and the mixture was heated at 90°C for 20 min. The mixture was allowed to cool to room temperature, evaporated to dryness and the residue was reconstituted in acetonitrile (200 μL) for GC-MS analysis. For NMR studies, 100 mg of bk-2C-B was pyrolyzed in a similar manner, using a 500-mL round-bottom flask. The pyrolysate was dissolved in deuterated chloroform.
Results and discussion
The bk-2C-B and bk-2C-I were both obtained from online vendors. The identity of the bk-2C-B was confirmed in a previous study. [11] While analysis by liquid chromatography-mass spectrometry (LC-MS) and NMR indicated the sample was not contaminated with by-products or adulterants, 1-(4-bromo-2,5-dimethoxyphenyl) ethanone and a pyrazine dimer were detected when the sample was run on GC-MS without derivatization. A potential reason for this formation might have included a catalytic conversion in the injection port liner due to the presence of active sites, which suggests that the extent of product formation might potentially vary across GC systems. In addition, it was determined that the purchased bk-2C-B was composed of mixture of chloride and bromide salts.
The GC-MS of the bk-2C-B and bk-2C-I are shown in Figure 2 . In addition to 1-(4-bromo-2,5-dimethoxyphenyl)ethanone and the pyrazine dimer reported by Power et al., [11] 5-(4-bromo-2,5-dimethoxyphenyl)oxazole was formed upon injection of the bk-2C-B on the GC. Whereas both 1-(4-iodo-2,5-dimethoxyphenyl) ethanone and 5-(4-iodo-2,5-dimethoxyphenyl)oxazole were present in the chromatogram of the bk-2C-I, the iodo dimer was not detected.
Pyrolysis products of bk-2C-B products were produced under conditions comparable to those employed by drug users using a 'meth pipe'. [15] The sample was heated with a butane lighter until yellow fumes appeared and an orange residue was deposited on the sides of the glass vial. The pyrolysis was repeated several times to determine which product were representative of those inhaled under the conditions used in drug abuse. A final pyrolysis was run with 9 mg to obtain sufficient product for the interpretation of the mass spectra. The substances reported here appeared in multiple pyrolysis runs.
Twelve pyrolysis products, shown in Figure 3 , were identified through interpretation of the mass spectra and confirmed by comparison to synthesized standards. The chromatograms of the pyrolates, standards, and mass spectra for products (1a)- (5) are shown in Figure 4 . Interpretation of the mass spectra for products (6)- (12) are shown in Figure 5 was aided by the characteristic isotope patterns of bromine and chlorine (Supporting Information).
The stability of the enol radical resulted in a distribution of products from homolytic reactions. Most of the pyrolysis products underwent homolytic cleavage of the C-N, although some C-C bond cleavage was observed. The mechanism for the haemolytic cleavage is shown in Figure 6 . The stereochemistry of the halogen addition also supports a haemolysis. Products (1a), (1b), (2) , (3), (5), (7) . and (8) also lost the beta ketone. The first peak detected at 6.18 min revealed co-elution of two pyrolates. One, 1-bromo-2,5-dimethoxy-4-methylbenzene (1a), was an example of beta C-O bond cleavage. The second was consistent with one or both phenols, 3-bromo-4-methoxyphenol and 2-bromo-4-methoxyphenol (1b), which illustrated activity at the benzene ring, resulting in both C-C cleavage and demethylation of the methoxy group. In comparison, the C-C cleavage was not observed in the pyrolysis of mephedrone. [17] The phenols were confirmed by derivatization with acetic anhydride where a gain in mass of 42 amu resulted in a retention time shift to 6.75 min. The mass spectrum of the derivatized phenol is shown in Figure 5 .
The formation of 1-bromo-4-ethyl-2,5-dimethoxy-benzene (2) was an example of deamination, as well as loss of the loss of oxygen in the ketone. The mechanism might have been similar to the formation of iso-mephedrone observed during mephedrone pyrolysis, with the formation of a cyclic amine intermediate that would result in the formation of an iso-2C-B intermediate, followed by deamination. [16] The peak eluting at 7.01 min was confirmed as 1-bromo-4-ethenyl-2,5-dimethoxybenzene (3). The fragmentation pattern representing the peak at 7.38 min was initially thought to represent 4-bromo-2,5-dimethoxybenzaldehyde but this was not confirmed when compared to a standard. Instead, an alternative structure was proposed, 1-(4-bromo-2-hydroxy-5-methoxyphenyl)ethanone (4), which was confirmed by comparison with a standard and by NMR provided in the Supporting Information. Other pyrolysis products that retained the ketone group included pyrolates (6), (9) , and (11). 1-(4-Bromo-2,5-dimethoxyphenyl)ethanone was formed by loss of the amine group, also seen in the pyrolysis of mephedrone. [16] In mephedrone, however, halogen substitution similar to 1-(4-bromo-2,5-dimethoxyphenyl)-2-chloro-ethanone (9) or 2-bromo-1-(4-bromo-2,5-dimethoxyphenyl)-ethanone (11) was not detected. In the later example, chlorination rather than bromination would occur in the case of mephedrone. Of the remaining products, (5), (7), and (8) were halogenated analogues of (1a), and (2). Two halogenated products were detected in the pyrolysis of mephedrone and identified as α-chloro ketones, 1-chloro-1-(4-methylphenyl)-2-propanone and 2-chloro-1-(4-methylphenyl)-1-propanone. [16] The pyrolysis products of bk-2C-B differed significantly from those observed with other phenethylamines [15] including methiopropamine and the ring-substituted cathinone, mephedrone. [15, 16] Methylation [18] and N,O rearrangement did not occur. [19] Product (1b) was unique in that the C-C bond cleavage appeared to occur at the benzene ring and the corresponding product was not detected in either the pyrolysis of methamphetamine or mephedrone. [16, 18] The (1b) and (4) represented reactions at the benzene ring, presumably through the formation of an alcohol from the associated methoxy group. Products (5), (7) (8) (9) , and (11) were the result of halogenation. Several products resulted from bond cleavage of either the α-β C-C bond (1a) or the C-N bond (2-4, 6) and similar products were detected in the pyrolysis of both methamphetamine and methiopropamine. [17, 18] Products (1a, 2, and 3) were analogous to the oxidative degradation products reported for methamphetamine. [18] Only two products retained the amine nitrogen: 5-(4-bromo-2,5-dimethoxyphenyl)oxazole (10) and a dimer (12) . These substances were present in the chromatograms of bk-2C-B as received and may be formed either during the pyrolysis or in the GC injector by a reaction of bk-2C-B as reported by Power et al. [11] A proposed mechanism for the fragmentation of product (10) is shown in Figure 7 , with formaldehyde being formed in situ from break down of the bk-2C-B.
Formation of the pyrazine dimer (12) may have formed through a condensation reaction of the β-ketone as seen in the report by Powers et al., although thermal rearrangements were also observed during mephedrone and methiopropamine pyrolysis. [16, 17] The difference in the products may have reflected the activating nature of the methoxy groups located on the benzene ring. Several products originating from oxidative degradation or bond cleavage showed a halogenated counterpart: compounds (7) and (8) were the chlorinated and brominated counterparts of (2) . Products (9 and 11) were the halogenated counterparts of (6). The halogenated counterparts for the phenols (1b and 4) were not detected.
While some level of toxicity is predicted for the α-chloro ketones, [20] no toxicity data are available for the substances formed during bk-2C-B pyrolysis. Products (1a, 2, and 5) have been studied as fungicides. [21] The ethenyl compound (3) has been researched for activity as a 2-photon chromophore. [22] Products (6 and 11) were used as precursors in the preparation of serotonin 5-HT 2A receptor agonists [10] and (1b) was identified as a precursor for 1,2-cyclized phenylethylamines studied as agonists for both 5-HT 2A and 5-HT 2B receptors. [23] A literature structure search for product (7) gave no results, whereas the analogous bromoethyl product (8) appeared in a study of phenylethylamine analogues for use in treating glaucoma. [24] As summarized in the Supporting Information, similar products were identified following the pyrolysis of bk-2C-I. The retention times increased as a reflection of increased mass of the iodine substituent. Products analogous to bk-2C-B (1-4), (6) (7) (8) and (10) were also formed during the pyrolysis of bk-2C-I. Two additional pyrolysis products were detected and tentatively identified through interpretation of their EI mass spectra. 1-(2,5-Dimethoxyphenyl)-ethanone (13) might have been formed by cleavage at the nitrogen and the decomposition product 1-iodo-4-ethenyl-5-methoxyphenol (14) might have been a decomposition product similar to 1-iodo-4-ethenyl-2,5-dimethoxy-benzene (3) and 1-(4-iodo-2-hydroxy-5-methoxyphenyl)-ethanone (4). The only bk-2C-I pyrolysis product mentioned in a biological study was the product (4) mentioned in a patent for P2X3 and P2X2/3 antagonists. [25] 
Conclusion
Inhalation of a vaporized drug commonly produces a quick onset of effects but also shorter duration. However, the potential ingestion of pyrolysis products with unknown toxicity adds an element of concern. Twelve products resulting from the pyrolysis of bk-2C-B have been identified and similar chemicals were detected for bk-2C-I. The pyrolysis conditions resulted primarily in oxidative degradation and C-C or N-C bond cleavage, often accompanied by halogenation.
